MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10549-022-06692-3

Медицинская библиотека · Breast cancer research and treatment · 2022

Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.

Samusieva Anastasiia, Serga Svitlana, Klymenko Sergiy, Rybchenko Lyudmila, Klimuk Bohdana, Zakhartseva Liubov, Gorovenko Natalia, Lobanova Olga, Rossokha Zoia, Fishchuk Liliia, Levkovich Nataliia, Medvedieva Nataliia, Popova Olena, Cheshuk Valeriy, Inomistova Mariia, Khranovska Natalia, Skachkova Oksana, Michailovich Yurii, Ponomarova Olga, Kozeretska Iryna

СтатьяПеревод в очереди

Аннотация

PURPOSE: The gene BRCA1 plays a key role in DNA repair in breast and ovarian cell lines and this is considered one of target tumor suppressor genes in same line of cancers. The 5382insC mutation is among the most frequently detected in patients (Eastern Europe) with triple-negative breast cancer (TNBC). In Ukraine, there is not enough awareness of necessity to test patients with TNBC for BRCA1 mutations. That is why this group of patients is not well-studied, even through is known the mutation may affect the course of disease.

METHODS

The biological samples of 408 female patients were analyzed of the 5382insC mutation in BRCA1. We compared the frequency of the 5382insC mutation in BRCA1 gene observed in Ukraine with known frequencies in other countries.

RESULTS

For patients with TNBC, BRCA1 mutations frequency was 11.3%, while in patients with luminal types of breast cancers, the frequency was 2.8%. Prevalence of 5382insC among TNBC patients reported in this study was not different from those in Tunisia, Poland, Russia, and Bulgaria, but was higher than in Australia and Germany.

CONCLUSION

The BRCA1 c.5382 mutation rate was recorded for the first time for TNBC patients in a Ukrainian population. The results presented in this study underscore the importance of this genetic testing of mutations in patients with TNBC. Our study supports BRCA1/2 genetic testing for all women diagnosed with TNBC, regardless of the age of onset or family history of cancer and not only for women diagnosed with TNBC at <60y.o., as guidelines recommend.

Для цитирования: Samusieva Anastasiia, Serga Svitlana, Klymenko Sergiy, Rybchenko Lyudmila, Klimuk Bohdana, Zakhartseva Liubov, Gorovenko Natalia, Lobanova Olga, Rossokha Zoia, Fishchuk Liliia, Levkovich Nataliia, Medvedieva Nataliia, Popova Olena, Cheshuk Valeriy, Inomistova Mariia, Khranovska Natalia, Skachkova Oksana, Michailovich Yurii, Ponomarova Olga, Kozeretska Iryna. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.. Breast cancer research and treatment. 2022. DOI: 10.1007/s10549-022-06692-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.